Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression
Dual human immunodeficiency virus (HIV) 1 and HIV-2 superinfections are rare but challenging. A HIV-1-infected patient receiving effective antiretroviral therapy was investigated for a severe CD4+ cell count decline. HIV-2 superinfection was diagnosed and genotypic test revealed mutations conferring resistance to most drug class, limiting options for treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
---|---|
Enthalten in: |
Open forum infectious diseases - 6(2019), 4 vom: 24. Apr., Seite ofz063 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ceia, F [VerfasserIn] |
---|
Links: |
---|
Themen: |
HIV-1 |
---|
Anmerkungen: |
Date Revised 30.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1093/ofid/ofz063 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295712155 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295712155 | ||
003 | DE-627 | ||
005 | 20231225084243.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ofid/ofz063 |2 doi | |
028 | 5 | 2 | |a pubmed24n0985.xml |
035 | |a (DE-627)NLM295712155 | ||
035 | |a (NLM)30949532 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ceia, F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Human Immunodeficiency Virus (HIV) 2 Superinfection in a Patient Receiving Antiretroviral Therapy With Longstanding HIV-1 Viral Load Suppression |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.09.2020 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Dual human immunodeficiency virus (HIV) 1 and HIV-2 superinfections are rare but challenging. A HIV-1-infected patient receiving effective antiretroviral therapy was investigated for a severe CD4+ cell count decline. HIV-2 superinfection was diagnosed and genotypic test revealed mutations conferring resistance to most drug class, limiting options for treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV-1 | |
650 | 4 | |a HIV-2 | |
650 | 4 | |a human immunodeficiency virus | |
650 | 4 | |a immunosuppression | |
650 | 4 | |a pre-exposure prophylaxis | |
700 | 1 | |a Silva-Pinto, A |e verfasserin |4 aut | |
700 | 1 | |a Carvalho, A C |e verfasserin |4 aut | |
700 | 1 | |a Piñeiro, C |e verfasserin |4 aut | |
700 | 1 | |a Soares, J |e verfasserin |4 aut | |
700 | 1 | |a Serrão, R |e verfasserin |4 aut | |
700 | 1 | |a Sarmento, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Open forum infectious diseases |d 2014 |g 6(2019), 4 vom: 24. Apr., Seite ofz063 |w (DE-627)NLM243576811 |x 2328-8957 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2019 |g number:4 |g day:24 |g month:04 |g pages:ofz063 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ofid/ofz063 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 6 |j 2019 |e 4 |b 24 |c 04 |h ofz063 |